e-Drug3D 1932 |
CEFIDEROCOL
|
cas 1225208-94-5 |
CLASS ANTIINFECTIVES |
ROUTE (list) INTRAVENOUS |
ATC code |
PK parameters VD 18 LITER |
Target TARGET PENICILLIN-BINDING PROTEINS (PBPS) |
DrugCentral Peptidoglycan synthase FtsI UNIPROT P0AD68 ftsI Penicillin-binding protein 1A UNIPROT Q07806 mrcA |
Download SDF file | Pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-[2-[(2-chloro-3,4-dihydroxybenzoyl)amino]ethyl]- Formula: Calculated chemical properties: MW 751.22 NB_atoms 50 XLogP -1.52 PSA 220.631 NB_HD 6 NB_HA 16 fsp3 0.43 Lipinski(0=no;1=yes) 0 |
FDA NDA 209445 (pdf not found) INN (CEFIDEROCOL SULFATE TOSYLATE) FETROJA (SHIONOGI INC) APPROVAL= AP YEAR= 2019 NEWMOLECULARENTITY |
Other links: |